Epicutaneous immunization with protein antigen TNP-Ig and NOD2 ligand muramyl dipeptide (MDP) reverses skin-induced suppression of contact hypersensitivity-Reference-Cited by-同舟云学术

Epicutaneous immunization with protein antigen TNP-Ig and NOD2 ligand muramyl dipeptide (MDP) reverses skin-induced suppression of contact hypersensitivity

Published:2014-02 Issue:1 Volume:66 Page:137-142
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacological Reports

Author:

Majewska-Szczepanik Monika,Dorożyńska Iwona,Strzępa Anna,Szczepanik Marian

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Reference29 articles.

1. Contact sensitivity to oxazolonein the mouse. VIII: demonstration of several classes of antibody in the sera of contact sensitized and immunized mice by a simplified antiglobulin assay;Askenase;Immunology,1972

2. TLR-dependent IL-4 production by invariant Valpha14+Jalpha18+NKT cells to initiate contact sensitivity in vivo;Askenase;J Immunol,2005

3. Development of immunoadjuvants for immunotherapy of cancer;Azuma;Int Immunopharmacol,2001

4. Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by synthetic immunoadjuvant (N-acetyl-muramyl-l-alanyl-d-isoglutamine) and several analogs;Chedid;Proc Natl Acad Sci U S A,1997

5. Nod2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation;Cooney;Nat Med,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracellular NOD2 Activation Promotes Maturation and Antigen-Presenting Functions of Dentritic Cells Exposed to Porphyromonas Gingivalis Lipopolysaccharide;Clinical Laboratory;2018

2. Corrigendum to “Epicutaneous immunization with protein antigen TNP-Ig and NOD2 ligand muramyl dipeptide (MDP) reverses skin-induced suppression of contact hypersensitivity” [Pharmacol. Rep. 66 (2014) 137–142];Pharmacological Reports;2017-06

3. Transdermal immunotherapy: Past, present and future;Pharmacological Reports;2016-08

4. Oral treatment with enrofloxacin early in life promotes Th2-mediated immune response in mice;Pharmacological Reports;2016-02